Novacyt Secures Australian Regulatory Clearance for Yourgene Insight Diagnostic Assay

MT Newswires · 2d ago
05:44 AM EST, 11/11/2026 (MT Newswires) -- Novacyt (NCYT.L) received Australian regulatory approval for its Yourgene Insight dihydropyrimidine dehydrogenase, or DPYD, assay. The approval from Australia's Therapeutic Goods Administration allows the French molecular diagnostics company's unit Southern Cross Diagnostics to market and supply the assay for clinical diagnostic testing in Australia, according to a Wednesday release. The test identifies 19 variants in the DPYD gene that signal a higher risk of severe or possibly fatal toxicity in patients undergoing 5-fluorouracil treatment.